Mexico Gastrointestinal OTC Drugs Market Research Report 2018

Publisher Name :
Date: 30-May-2018
No. of pages: 106
Inquire Before Buying

The global Gastrointestinal OTC Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Mexico plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Gastrointestinal OTC Drugs development status and future trend in Mexico, focuses on top players in Mexico, also splits Gastrointestinal OTC Drugs by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

The major players in Mexico market include

- Bayer

- GlaxoSmithKline

- Johnson & Johnson

- Pfizer

- Perrigo

- Abbott

- C.B. Fleet

- Purdue Pharma

- Teva Pharmaceutical

- Sanofi

- Boehringer Ingelheim

- Xiuzheng Pharmaceutical Group

- China Resources Sanjiu Medical & Pharmaceutical

- Harbin Pharmaceutical Group

- JZJT

- Tongrentang (TRT)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

- Capsule

- Tablet

- Others

On the basis of the end users/Application, this report covers

- Hospital Pharmacy

- Retail Pharmacy

- Online Pharmacy

Mexico Gastrointestinal OTC Drugs Market Research Report 2018

Table of Contents
Mexico Gastrointestinal OTC Drugs Market Research Report 2018
1 Gastrointestinal OTC Drugs Overview
1.1 Product Overview and Scope of Gastrointestinal OTC Drugs
1.2 Classification of Gastrointestinal OTC Drugs by Product Category
1.2.1 Mexico Gastrointestinal OTC Drugs Sales (K Pcs) Comparison by Type (2013-2025)
1.2.2 Mexico Gastrointestinal OTC Drugs Sales (K Pcs) Market Share by Type in 2017
1.2.3 Capsule
1.2.4 Tablet
1.2.5 Others
1.3 Mexico Gastrointestinal OTC Drugs Market by Application/End Users
1.3.1 Mexico Gastrointestinal OTC Drugs Sales (K Pcs) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Mexico Revenue and Sales of Gastrointestinal OTC Drugs (2013-2025)
1.4.1 Mexico Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (%)(2013-2025)
1.4.2 Mexico Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
2 Mexico Gastrointestinal OTC Drugs Market Competition by Players/Manufacturers
2.1 Mexico Gastrointestinal OTC Drugs Sales (K Pcs) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 Mexico Gastrointestinal OTC Drugs Revenue and Share by Players/Manufacturers (2013-2018)
2.3 Mexico Gastrointestinal OTC Drugs Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 Mexico Gastrointestinal OTC Drugs Market Competitive Situation and Trends
2.4.1 Mexico Gastrointestinal OTC Drugs Market Concentration Rate
2.4.2 Mexico Gastrointestinal OTC Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in Mexico Market
2.5 Mexico Players/Manufacturers Gastrointestinal OTC Drugs Manufacturing Base Distribution, Sales Area, Product Type
3 Mexico Gastrointestinal OTC Drugs Sales and Revenue (Value) by Type (2013-2018)
3.1 Mexico Gastrointestinal OTC Drugs Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
3.2 Mexico Gastrointestinal OTC Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 Mexico Gastrointestinal OTC Drugs Price (USD/Pcs) by Type (2013-2018)
3.4 Mexico Gastrointestinal OTC Drugs Sales Growth Rate (%) by Type (2013-2018)
4 Mexico Gastrointestinal OTC Drugs Sales by Application (2013-2018)
4.1 Mexico Gastrointestinal OTC Drugs Sales (K Pcs) and Market Share by Application (2013-2018)
4.2 Mexico Gastrointestinal OTC Drugs Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities
5 Mexico Gastrointestinal OTC Drugs Players/Suppliers Profiles and Sales Data
5.1 Bayer
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
5.1.2.1 Product A
5.1.2.2 Product B
5.1.3 Bayer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.1.4 Main Business/Business Overview
5.2 GlaxoSmithKline
5.2.1 Company Basic Information, Manufacturing Base and Competitors
5.2.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
5.2.2.1 Product A
5.2.2.2 Product B
5.2.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.2.4 Main Business/Business Overview
5.3 Johnson & Johnson
5.3.1 Company Basic Information, Manufacturing Base and Competitors
5.3.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
5.3.2.1 Product A
5.3.2.2 Product B
5.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.3.4 Main Business/Business Overview
5.4 Pfizer
5.4.1 Company Basic Information, Manufacturing Base and Competitors
5.4.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
5.4.2.1 Product A
5.4.2.2 Product B
5.4.3 Pfizer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.4.4 Main Business/Business Overview
5.5 Perrigo
5.5.1 Company Basic Information, Manufacturing Base and Competitors
5.5.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
5.5.2.1 Product A
5.5.2.2 Product B
5.5.3 Perrigo Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.5.4 Main Business/Business Overview
5.6 Abbott
5.6.1 Company Basic Information, Manufacturing Base and Competitors
5.6.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
5.6.2.1 Product A
5.6.2.2 Product B
5.6.3 Abbott Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.6.4 Main Business/Business Overview
5.7 C.B. Fleet
5.7.1 Company Basic Information, Manufacturing Base and Competitors
5.7.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
5.7.2.1 Product A
5.7.2.2 Product B
5.7.3 C.B. Fleet Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.7.4 Main Business/Business Overview
5.8 Purdue Pharma
5.8.1 Company Basic Information, Manufacturing Base and Competitors
5.8.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
5.8.2.1 Product A
5.8.2.2 Product B
5.8.3 Purdue Pharma Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.8.4 Main Business/Business Overview
5.9 Teva Pharmaceutical
5.9.1 Company Basic Information, Manufacturing Base and Competitors
5.9.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
5.9.2.1 Product A
5.9.2.2 Product B
5.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.9.4 Main Business/Business Overview
5.10 Sanofi
5.10.1 Company Basic Information, Manufacturing Base and Competitors
5.10.2 Gastrointestinal OTC Drugs Product Category, Application and Specification
5.10.2.1 Product A
5.10.2.2 Product B
5.10.3 Sanofi Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
5.10.4 Main Business/Business Overview
5.11 Boehringer Ingelheim
5.12 Xiuzheng Pharmaceutical Group
5.13 China Resources Sanjiu Medical & Pharmaceutical
5.14 Harbin Pharmaceutical Group
5.15 JZJT
5.16 Tongrentang (TRT)
6 Gastrointestinal OTC Drugs Manufacturing Cost Analysis
6.1 Gastrointestinal OTC Drugs Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Gastrointestinal OTC Drugs
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Gastrointestinal OTC Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Gastrointestinal OTC Drugs Major Manufacturers in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 Mexico Gastrointestinal OTC Drugs Market Size (Sales and Revenue) Forecast (2018-2025)
10.1 Mexico Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
10.2 Mexico Gastrointestinal OTC Drugs Sales (K Pcs) Forecast by Type (2018-2025)
10.3 Mexico Gastrointestinal OTC Drugs Sales (K Pcs) Forecast by Application (2018-2025)
11 Research Findings and Conclusion
List of Tables and Figures
Figure Mexico Market Size (Million USD) Status and Outlook (2013-2025)
Table Gastrointestinal OTC Drugs Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Gastrointestinal OTC Drugs Sales (K Pcs) by Application (2017-2025)
Figure Product Picture of Gastrointestinal OTC Drugs
Table Mexico Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)
Figure Mexico Gastrointestinal OTC Drugs Sales Volume Market Share by Type in 2017
Figure Capsule Product Picture
Figure Tablet Product Picture
Figure Others Product Picture
Figure Mexico Gastrointestinal OTC Drugs Sales (K Pcs) Comparison by Application (2013-2025)
Figure Mexico Sales Market Share (%) of Gastrointestinal OTC Drugs by Application in 2017
Figure Hospital Pharmacy Examples
Figure Retail Pharmacy Examples
Figure Online Pharmacy Examples
Figure Mexico Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure Mexico Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Mexico Gastrointestinal OTC Drugs Sales of Key Players/Manufacturers (2013-2018)
Table Mexico Gastrointestinal OTC Drugs Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Mexico Gastrointestinal OTC Drugs Sales Share (%) by Players/Manufacturers
Figure 2017 Mexico Gastrointestinal OTC Drugs Sales Share (%) by Players/Manufacturers
Table Mexico Gastrointestinal OTC Drugs Revenue by Players/Manufacturers (2013-2018)
Table Mexico Gastrointestinal OTC Drugs Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Mexico Gastrointestinal OTC Drugs Revenue Share (%) by Players/Manufacturers
Figure 2017 Mexico Gastrointestinal OTC Drugs Revenue Share (%) by Players/Manufacturers
Table Mexico Market Gastrointestinal OTC Drugs Average Price (USD/Pcs) of Key Players/Manufacturers (2013-2018)
Figure Mexico Market Gastrointestinal OTC Drugs Average Price (USD/Pcs) of Key Players/Manufacturers in 2017
Figure Mexico Gastrointestinal OTC Drugs Market Share of Top 3 Players/Manufacturers
Figure Mexico Gastrointestinal OTC Drugs Market Share of Top 5 Players/Manufacturers
Table Mexico Players/Manufacturers Gastrointestinal OTC Drugs Manufacturing Base Distribution and Sales Area
Table Mexico Players/Manufacturers Gastrointestinal OTC Drugs Product Category
Table Mexico Gastrointestinal OTC Drugs Sales (K Pcs) by Type (2013-2018)
Table Mexico Gastrointestinal OTC Drugs Sales Share (%) by Type (2013-2018)
Figure Mexico Gastrointestinal OTC Drugs Sales Share (%) by Type (2013-2018)
Figure Mexico Gastrointestinal OTC Drugs Sales Market Share (%) by Type in 2017
Table Mexico Gastrointestinal OTC Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Mexico Gastrointestinal OTC Drugs Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Gastrointestinal OTC Drugs by Type (2013-2018)
Figure Revenue Market Share of Gastrointestinal OTC Drugs by Type in 2017
Table Mexico Gastrointestinal OTC Drugs Price (USD/Pcs) by Type (2013-2018)
Figure Mexico Gastrointestinal OTC Drugs Sales Growth Rate (%) by Type (2013-2018)
Table Mexico Gastrointestinal OTC Drugs Sales (K Pcs) by Application (2013-2018)
Table Mexico Gastrointestinal OTC Drugs Sales Market Share (%) by Application (2013-2018)
Figure Mexico Gastrointestinal OTC Drugs Sales Market Share (%) by Application (2013-2018)
Figure Mexico Gastrointestinal OTC Drugs Sales Market Share (%) by Application in 2017
Table Mexico Gastrointestinal OTC Drugs Sales Growth Rate (%) by Application (2013-2018)
Figure Mexico Gastrointestinal OTC Drugs Sales Growth Rate (%) by Application (2013-2018)
Table Bayer Gastrointestinal OTC Drugs Basic Information List
Table Bayer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Bayer Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Bayer Gastrointestinal OTC Drugs Sales Market Share (%) in Mexico (2013-2018)
Figure Bayer Gastrointestinal OTC Drugs Revenue Market Share (%) in Mexico (2013-2018)
Table GlaxoSmithKline Gastrointestinal OTC Drugs Basic Information List
Table GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure GlaxoSmithKline Gastrointestinal OTC Drugs Sales Market Share (%) in Mexico (2013-2018)
Figure GlaxoSmithKline Gastrointestinal OTC Drugs Revenue Market Share (%) in Mexico (2013-2018)
Table Johnson & Johnson Gastrointestinal OTC Drugs Basic Information List
Table Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Johnson & Johnson Gastrointestinal OTC Drugs Sales Market Share (%) in Mexico (2013-2018)
Figure Johnson & Johnson Gastrointestinal OTC Drugs Revenue Market Share (%) in Mexico (2013-2018)
Table Pfizer Gastrointestinal OTC Drugs Basic Information List
Table Pfizer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Pfizer Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Pfizer Gastrointestinal OTC Drugs Sales Market Share (%) in Mexico (2013-2018)
Figure Pfizer Gastrointestinal OTC Drugs Revenue Market Share (%) in Mexico (2013-2018)
Table Perrigo Gastrointestinal OTC Drugs Basic Information List
Table Perrigo Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Perrigo Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Perrigo Gastrointestinal OTC Drugs Sales Market Share (%) in Mexico (2013-2018)
Figure Perrigo Gastrointestinal OTC Drugs Revenue Market Share (%) in Mexico (2013-2018)
Table Abbott Gastrointestinal OTC Drugs Basic Information List
Table Abbott Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Abbott Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Abbott Gastrointestinal OTC Drugs Sales Market Share (%) in Mexico (2013-2018)
Figure Abbott Gastrointestinal OTC Drugs Revenue Market Share (%) in Mexico (2013-2018)
Table C.B. Fleet Gastrointestinal OTC Drugs Basic Information List
Table C.B. Fleet Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure C.B. Fleet Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure C.B. Fleet Gastrointestinal OTC Drugs Sales Market Share (%) in Mexico (2013-2018)
Figure C.B. Fleet Gastrointestinal OTC Drugs Revenue Market Share (%) in Mexico (2013-2018)
Table Purdue Pharma Gastrointestinal OTC Drugs Basic Information List
Table Purdue Pharma Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Purdue Pharma Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Purdue Pharma Gastrointestinal OTC Drugs Sales Market Share (%) in Mexico (2013-2018)
Figure Purdue Pharma Gastrointestinal OTC Drugs Revenue Market Share (%) in Mexico (2013-2018)
Table Teva Pharmaceutical Gastrointestinal OTC Drugs Basic Information List
Table Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Teva Pharmaceutical Gastrointestinal OTC Drugs Sales Market Share (%) in Mexico (2013-2018)
Figure Teva Pharmaceutical Gastrointestinal OTC Drugs Revenue Market Share (%) in Mexico (2013-2018)
Table Sanofi Gastrointestinal OTC Drugs Basic Information List
Table Sanofi Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Sanofi Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Sanofi Gastrointestinal OTC Drugs Sales Market Share (%) in Mexico (2013-2018)
Figure Sanofi Gastrointestinal OTC Drugs Revenue Market Share (%) in Mexico (2013-2018)
Table Boehringer Ingelheim Gastrointestinal OTC Drugs Basic Information List
Table Xiuzheng Pharmaceutical Group Gastrointestinal OTC Drugs Basic Information List
Table China Resources Sanjiu Medical & Pharmaceutical Gastrointestinal OTC Drugs Basic Information List
Table Harbin Pharmaceutical Group Gastrointestinal OTC Drugs Basic Information List
Table JZJT Gastrointestinal OTC Drugs Basic Information List
Table Tongrentang (TRT) Gastrointestinal OTC Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal OTC Drugs
Figure Manufacturing Process Analysis of Gastrointestinal OTC Drugs
Figure Gastrointestinal OTC Drugs Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal OTC Drugs Major Players/Manufacturers in 2017
Table Major Buyers of Gastrointestinal OTC Drugs
Table Distributors/Traders List
Figure Mexico Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Mexico Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Mexico Gastrointestinal OTC Drugs Price (USD/Pcs) Trend Forecast (2018-2025)
Table Mexico Gastrointestinal OTC Drugs Sales (K Pcs) Forecast by Type (2018-2025)
Figure Mexico Gastrointestinal OTC Drugs Sales (K Pcs) Forecast by Type (2018-2025)
Figure Mexico Gastrointestinal OTC Drugs Sales Volume Market Share Forecast by Type in 2025
Table Mexico Gastrointestinal OTC Drugs Sales (K Pcs) Forecast by Application (2018-2025)
Figure Mexico Gastrointestinal OTC Drugs Sales Volume Market Share Forecast by Application (2018-2025)
Figure Mexico Gastrointestinal OTC Drugs Sales Volume Market Share Forecast by Application in 2025
  • 2015-2023 World Drugs for Traveler's Diarrhea Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 12-Sep-2018        Price: US 2800 Onwards        Pages: 97
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Market Segment as follows: By Region / Countries - North America (U.S., Canada, Mexico) - Europe (Germany, U.K., France, Italy, Russia, Spain etc) - South America (Brazil, Argentina etc)......
  • Gastric Ulcers - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 44
    Gastric Ulcers - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Ulcers - Pipeline Review, H2 2018, provides an overview of the Gastric Ulcers (Gastrointestinal) pipeline landscape. Gastric ulcer is a painful sore or ulcer in the lining of stomach. The most common cause of gastric ulcer is Helicobacter pylori bacterial infection. Symptoms include pain, bloating, retching, nausea or......
  • Celiac Disease - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 85
    Celiac Disease - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Celiac Disease - Pipeline Review, H2 2018, provides an overview of the Celiac Disease (Gastrointestinal) pipeline landscape. Celiac disease is an autoimmune disorder caused by an immune response to wheat protein gluten. Symptoms include weight loss, vomiting, abdominal bloating, abdominal pain and persistent diarrhea. Risk fa......
  • Pancreatitis - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 87
    Pancreatitis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatitis - Pipeline Review, H2 2018, provides an overview of the Pancreatitis (Gastrointestinal) pipeline landscape. Pancreatitis is an inflammation of pancreas. Symptoms include upper abdominal pain, nausea, vomiting, and tenderness when touching the abdomen, weight loss and upper abdominal pain. Predisposing factors inclu......
  • Alcoholic Hepatitis - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 76
    Alcoholic Hepatitis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alcoholic Hepatitis - Pipeline Review, H2 2018, provides an overview of the Alcoholic Hepatitis (Gastrointestinal) pipeline landscape. Alcoholic hepatitis is an inflammation of the liver. It is typically caused by excessive alcohol consumption over a long period of time. Symptoms include changes in appetite, dry mouth, w......
  • Digital Landscape: Inflammatory Bowel Disease
    Published: 06-Sep-2018        Price: US 6000 Onwards        Pages: 159
    Digital Landscape: Inflammatory Bowel Disease Summary The Digital Landscape Inflammatory Bowel Disease report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn's disease and ulcerative colitis (UC). Key Highlights - US Patients: AbbVie offers the strongest support for IBD patients in the US, particularly branded, unbranded and mobile app. Janssen......
  • Global Inflammatory Bowel Disease Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Inflammatory Bowel Disease Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides ......
  • Global Gastrointestinal Symptoms Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Gastrointestinal Symptoms Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides u......
  • Global Irritable Bowel Syndrome Partnering 2012-2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Irritable Bowel Syndrome Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides un......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs